Type I hypersensitivity reactions in intestinal mucosae from rats infected with Fasciola hepatica.
Type I hypersensitivity reactions in the intestinal tract of sensitized animals may contribute to resistance to reinfection with Fasciola hepatica. Colonic mucosae isolated from previously infected rats were voltage clamped in Ussing chambers. Antigen was prepared as a crude homogenate from adult liver fluke. Assay of serum antibodies against fluke antigen confirmed sensitization. Antigen challenge evoked a rapid onset, transient inward current in sensitized but not in control preparations. Chloride secretion accounted for at least part of the response since the loop diuretic bumetanide reduced the effect of antigen by 61%. Anti-rat IgE mimicked the response to antigen and desensitized tissues to subsequent antigen challenge. Local synthesis of eicosanoids may mediate the response to antigen since the cyclo-oxygenase inhibitor piroxicam reduced the response by 76%. In contrast, mepyramine which is a histamine receptor antagonist did not alter the ion transport response evoked by antigen. Tetrodotoxin reduced the response to antigen by 53% implicating intrinsic neurons within the lamina propria as effector cells in the responses of this tissue to antigen. We propose that antigen stimulation of electrogenic chloride movement and consequent fluid secretion in vivo may contribute to a local effector mechanism in prevention of reinfection of previously sensitized hosts.
O'Malley
K E
KE
Department of Pharmacology, University College Dublin, Belfield, Ireland.
Sloan
T
T
Joyce
P
P
Baird
A W
AW
D000109:Acetylcholine / Q000502:physiology; D000704:Analysis of Variance; D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology / Q000502:physiology; D002713:Chlorine / Q000378:metabolism; D003106:Colon / Q000378:metabolism; D005211:Fascioliasis / Q000276:immunology*; D006969:Hypersensitivity, Immediate / Q000378:metabolism; D007082:Ileum / Q000378:metabolism; D007073:Immunoglobulin E / Q000276:immunology; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000276:immunology* / Q000378:metabolism; D017136:Ion Transport / Q000187:drug effects / Q000276:immunology; D008297:Male; D010894:Piroxicam / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011969:Receptors, Histamine H1 / Q000502:physiology; D013779:Tetrodotoxin / Q000494:pharmacology; D013997:Time Factors
D000947:Antigens, Helminth; D011969:Receptors, Histamine H1; D010894:Piroxicam; D007073:Immunoglobulin E; D013779:Tetrodotoxin; D002713:Chlorine; D011451:Prostaglandin-Endoperoxide Synthases; D011738:Pyrilamine; D000109:Acetylcholine